Category: Biotechnology company
Quick infos Headquarters: Farmingdale, New York, United States Trade prices Volume: Market Cap: 117.88M Prev closed: 2.47 Open: 2.5 High: 2.68 Low: 2.45 52 week low: 1.56 52 week high: 4.85 Dividends: No Dividends Next ER: December 12, 2022 After Market Closes
Company Profile Enzo Biochem is a leading life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and provides reference laboratory services to the medical community.
Earnings History Date EPS / Forecast Revenue / Forecast December 12, 2022 - / - - / - October 14, 2022 -0.17 / -20.28M / -Beat! June 9, 2022 -0.1 / -26.22M / -Beat! March 14, 2022 -0.05 / -34.05M / -Beat! December 15, 2021 0.07 / -26.52M / -Beat! view more
Historical Data Date Price Open High Low Vol Change ER Jun 8, 2022 2.410 2.480 2.500
2.380
18.78K -1.63% Jun 7, 2022 2.450 2.450 2.480
2.390
22.73K 0.41% Jun 6, 2022 2.440 2.470 2.481
2.420
32.84K -0.41% Jun 3, 2022 2.450 2.469 2.469
2.400
20.67K 1.24% Jun 2, 2022 2.420 2.300 2.440
2.290
31.43K 4.76% Jun 1, 2022 2.310 2.340 2.350
2.230
99.85K 0% May 31, 2022 2.310 2.290 2.370
2.240
86.43K 2.21% May 27, 2022 2.260 2.170 2.320
2.170
75.53K 2.26% May 26, 2022 2.210 2.350 2.420
2.210
134.29K -3.91% May 25, 2022 2.300 2.350 2.350
2.272
25.96K -0.43% view more
NYSE - New York Stock Exchange
More profiles and info about the company Founded:1976 Employees:460 News
Enzo Biochem Non-GAAP EPS of -$0.17, revenue of $20.28M seekingalpha.com Oct 14, 2022 7:36 pm Enzo Biochem GAAP EPS of -$0.10, revenue of $26.2M seekingalpha.com Jun 10, 2022 4:34 am Enzo Biochem gains on New York approval for test to detect human papillomavirus seekingalpha.com Apr 19, 2022 8:49 pm
Enzo Biochem: Fiscal 4Q Earnings Snapshot finance.yahoo.com Oct 14, 2020 4:17 am
German laboratories group Synlab hires banks for 2021 IPO - sources finance.yahoo.com Oct 14, 2020 12:17 am
Stone Ridge Calls Its $114M in Bitcoin ‘Primary Treasury Reserve Asset’;
NYDIG Unit Raises $50M finance.yahoo.com Oct 14, 2020 12:17 am Enzo Biochem names Kara Cannon as operating chief seekingalpha.com Mar 29, 2022 4:24 am Enzo Biochem Non-GAAP EPS of $0.03, revenue of $34.05M seekingalpha.com Mar 15, 2022 4:12 am Enzo Biochem issues notice of termination for CEO Elazar Rabbani seekingalpha.com Jan 22, 2022 5:45 am Enzo Biochem reports Q1 results seekingalpha.com Dec 16, 2021 5:09 am Enzo Biochem names new CEO replacing Elazar Rabbani seekingalpha.com Oct 18, 2021 8:45 pm This week's under the radar earnings reports seekingalpha.com Oct 16, 2021 2:39 am Enzo Biochem shares fall after operational development update, Q4 results seekingalpha.com Oct 12, 2021 10:27 pm Enzo Biochem reports Q4 results seekingalpha.com Oct 12, 2021 7:29 pm Enzo Biochem shares rise on FDA EUA expansion for SARS-CoV-2 test seekingalpha.com Jul 20, 2021 8:41 pm Enzo Biochem rises as profitability continues after near twofold rise in revenue seekingalpha.com Jun 10, 2021 8:16 pm Enzo Biochem reports FQ3 results seekingalpha.com Jun 10, 2021 4:13 am Enzo Biochem board rejects founder’s resignation seekingalpha.com Mar 20, 2021 5:09 am Enzo Biochem moves commended by top investor seekingalpha.com Mar 17, 2021 4:05 am Enzo Biochem CEO to step down seekingalpha.com Mar 16, 2021 4:30 am This company doesn't provide a dividend.
Talk about Enzo Biochem, Inc. below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.
The best book on investing ever written. -- Warren Buffet